C
KP Tissue Inc. KPTSF
$7.80 $0.030.39% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

Company Overview

KP Tissue Inc. is a Canada-based holding company whose primary purpose is to own an equity interest in Kruger Products Inc., one of the largest manufacturers of tissue products in North America. The company operates within the consumer staples industry, specifically the household paper and personal hygiene products segment. KP Tissue does not have operating activities of its own; instead, its financial performance is derived almost entirely from its investment in Kruger Products.

The company’s core revenue exposure is linked to consumer demand for toilet paper, facial tissue, paper towels, and related products sold under both branded and private-label offerings. Key customer segments include mass retailers, grocery chains, and institutional customers across North America. KP Tissue’s strategic positioning is tied to Kruger Products’ scale manufacturing capabilities, established brands, and vertically integrated supply chain, including pulp sourcing. KP Tissue was incorporated in 2012 as part of a reorganization that allowed Kruger Inc. to monetize a portion of its tissue business while retaining operational control.

Business Operations

KP Tissue’s sole operating segment is its equity ownership in Kruger Products Inc., which represents substantially all assets, earnings, and cash flow. Kruger Products generates revenue through the manufacture and sale of consumer and away-from-home tissue products, with well-known brands such as Cashmere, Scotties, SpongeTowels, and Purex, alongside private-label production for major retailers.

Operations span both Canada and the United States, with multiple manufacturing facilities and distribution centers. Kruger Products controls key production technologies related to tissue conversion, pulp processing, and packaging, supported by long-term fiber supply arrangements. KP Tissue has no employees and no direct commercial partnerships; all operating, capital investment, and commercial activities are executed at the Kruger Products level, which remains controlled by Kruger Inc. through super-voting shares.

Strategic Position & Investments

KP Tissue’s strategic direction is directly aligned with the long-term strategy of Kruger Products Inc., which focuses on capacity expansion, operational efficiency, and product innovation in premium and sustainable tissue categories. Growth initiatives have included significant capital investments in new manufacturing facilities and machine upgrades designed to improve cost competitiveness and environmental performance.

Major investments have historically included new tissue manufacturing plants in North America and modernization of existing assets, rather than acquisitions. KP Tissue does not directly hold a diversified investment portfolio; its sole material investment is its interest in Kruger Products Inc. Exposure to emerging areas such as recyclable packaging, fiber efficiency, and lower-carbon manufacturing is achieved indirectly through Kruger Products’ sustainability and innovation programs.

Geographic Footprint

KP Tissue is headquartered in Canada, with its corporate presence linked to that of Kruger Products Inc. The operating footprint is concentrated in North America, with significant manufacturing and sales operations across Canada and the United States.

Kruger Products distributes products nationwide in both countries and serves a broad range of retail and commercial customers. While sales are primarily North American, the company’s scale, sourcing, and capital investments give it regional influence across the continental tissue market rather than a global operational presence.

Leadership & Governance

KP Tissue’s governance structure reflects its role as a holding company, with strategic oversight closely tied to Kruger Inc., the controlling shareholder of Kruger Products. The board and executive leadership emphasize long-term value creation, stable dividends, disciplined capital investment, and alignment with consumer staples market fundamentals.

Key executives associated with KP Tissue and Kruger Products include:

  • Dino Bianco – Chief Executive Officer
  • Andre Houle – Chief Financial Officer
  • Eric Ashworth – Chief Operating Officer
  • Susan Irving – Chief Marketing Officer
  • Chris Campbell – Chief Human Resources Officer

Leadership philosophy centers on operational excellence, brand stewardship, and sustainable manufacturing, with governance practices shaped by public company reporting requirements and majority ownership by a long-established private enterprise.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $182.08
B
AAPL NASDAQ $258.90
B
AVGO NASDAQ $350.63
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $127.26
B
B
Top Financial Stocks
See All »
B
B
JPM NYSE $307.97
B
V NYSE $308.96
Top Energy Stocks
See All »
Top Health Care Stocks
See All »
B
LLY NYSE $953.30
B
JNJ NYSE $241.30
B
AMGN NASDAQ $349.81
Top Real Estate Stocks
See All »
B
PLD NYSE $137.41